News

Cigna: Price Pullback Is A Great Opportunity
Cigna trades at a significant discount to the S&P 500, offering a higher yield and faster dividend growth, making it ...
BenefitsPRO2d
Cigna's PBM expands low-copay access to popular GLP-1s
The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...
The American Journal of Managed Care2d
The Future of Drug Pricing: Most Favored Nation, PBMs, and Patient Access
Navigating 2025 Drug Pricing Policies webinar, panelists discussed the Most Favored Nation executive order, bills aimed at ...
BenefitsPRO2d
Rep. Carter introduces major PBM reform bill with bipartisan support
One section could put HHS Secretary Robert F. Kennedy Jr. in charge of making sure PBMs send employer plan sponsors detailed ...
Zacks Investment Research on MSN2d
UnitedHealth vs. Cigna: Which Insurer to Buy Amid Sector Turmoil?
UnitedHealth Group Incorporated UNH and The Cigna Group CI are two leading players in U.S. managed care insurance, offering ...
Eli Lilly Has Seized the Lead in Anti-Obesity Drugs. Next Up: a Pill.
The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should see earnings gains through the end of the decade.
An Opioid Defendant Sought Records From 1,000+ Cities and Counties. So Far, It's Sued Five of Them.
OptumRx, a pharmacy benefit manager accused in hundreds of lawsuits of contributing to the opioid crisis, sued five Kentucky ...
PBIRx Announces Strategic Hiring Amidst Continued Growth and Client Acquisitions
PBIRx, Inc., a leader in pharmacy benefit consulting and auditing, is proud to announce the addition of several highly ...
RxLogic Appoints William Figueroa as Chief Information & Technology Officer to Advance Tech Strategy Supporting Company Growth and Expansion
RxLogic, a leading technology company for pharmacy benefit claims processing that provides a SaaS-based platform of smart ...
Gallagher Study Reveals Employers Investing in Holistic Wellbeing for Future Growth
In response to macro uncertainty and rising costs, employers are increasingly prioritizing comprehensive wellbeing strategies ...
Major insurance changes are coming to GLP-1 drugs for weight loss. Here’s how that could affect patients
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...